Labcorp Holdings Inc. (NYSE: LH) has declared a cash dividend of $0.72 per share of common stock, payable on September 11, 2025, to stockholders of record as of the close of business on August 28, 2025. Labcorp is a global leader of innovative and comprehensive laboratory services, with nearly 70,000 employees serving clients in approximately 100 countries.
In 2024, Labcorp provided support for 75% of the new drugs and therapeutic products approved by the FDA and performed more than 700 million tests annually for patients around the world. Additionally, the company's insights and laboratory capabilities advanced science to improve health and lives.
Investors will be keen to note the dividend amount, as it provides a direct return on their investment. This announcement also reflects the company's confidence in its financial position and ability to generate sustained earnings.
Labcorp's continued commitment to delivering value to its shareholders through dividends demonstrates its solid financial performance and ability to generate strong cash flows. The market has reacted to these announcements by moving the company's shares -2.06% to a price of $253.73. Check out the company's full 8-K submission here.
